» Articles » PMID: 17008597

Hypoxia-induced Pulmonary Vascular Remodeling: Cellular and Molecular Mechanisms

Overview
Journal Circ Res
Date 2006 Sep 30
PMID 17008597
Citations 474
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic hypoxic exposure induces changes in the structure of pulmonary arteries, as well as in the biochemical and functional phenotypes of each of the vascular cell types, from the hilum of the lung to the most peripheral vessels in the alveolar wall. The magnitude and the specific profile of the changes depend on the species, sex, and the developmental stage at which the exposure to hypoxia occurred. Further, hypoxia-induced changes are site specific, such that the remodeling process in the large vessels differs from that in the smallest vessels. The cellular and molecular mechanisms vary and depend on the cellular composition of vessels at particular sites along the longitudinal axis of the pulmonary vasculature, as well as on local environmental factors. Each of the resident vascular cell types (ie, endothelial, smooth muscle, adventitial fibroblast) undergo site- and time-dependent alterations in proliferation, matrix protein production, expression of growth factors, cytokines, and receptors, and each resident cell type plays a specific role in the overall remodeling response. In addition, hypoxic exposure induces an inflammatory response within the vessel wall, and the recruited circulating progenitor cells contribute significantly to the structural remodeling and persistent vasoconstriction of the pulmonary circulation. The possibility exists that the lung or lung vessels also contain resident progenitor cells that participate in the remodeling process. Thus the hypoxia-induced remodeling of the pulmonary circulation is a highly complex process where numerous interactive events must be taken into account as we search for newer, more effective therapeutic interventions. This review provides perspectives on each of the aforementioned areas.

Citing Articles

High-altitude pulmonary hypertension: a comprehensive review of mechanisms and management.

Yang X, Liu H, Wu X Clin Exp Med. 2025; 25(1):79.

PMID: 40063280 PMC: 11893705. DOI: 10.1007/s10238-025-01577-3.


Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling.

Zhang J, Ye X, Liu X, Zhang H, Qiao Q World J Cardiol. 2025; 17(1):101491.

PMID: 39866213 PMC: 11755123. DOI: 10.4330/wjc.v17.i1.101491.


GATA2 participates in protection against hypoxia-induced pulmonary vascular remodeling.

Shirota Y, Ohmori S, Engel J, Moriguchi T PLoS One. 2024; 19(12):e0315446.

PMID: 39739870 PMC: 11687799. DOI: 10.1371/journal.pone.0315446.


Transcriptome Analysis of Fibroblasts in Hypoxia-Induced Vascular Remodeling: Functional Roles of CD26/DPP4.

Suzuki Y, Kawasaki T, Tatsumi K, Okaya T, Sato S, Shimada A Int J Mol Sci. 2024; 25(23).

PMID: 39684311 PMC: 11640941. DOI: 10.3390/ijms252312599.


RO4929097 inhibits NICD3 to alleviate pulmonary hypertension via blocking Notch3/HIF-2α/FoxM1 signaling pathway.

Zhu H, Li C, Hu F, Wu L, Wu L, Zhou M In Vitro Cell Dev Biol Anim. 2024; 61(1):107-116.

PMID: 39621175 DOI: 10.1007/s11626-024-00976-2.